The Cell Culture Market to Reach $48.63 Billion by 2029, Driven by Advances in Biopharmaceuticals and the Rising Demand for Monoclonal Antibodies
Meticulous Research®, a leading provider of market
intelligence, has released a comprehensive report titled, “Cell Culture
Market by Product [Consumables (Media, Reagents, Sera, Cell Lines), Equipment
(Bioreactors, Centrifuges, Cell Counters)], Application (Bioproduction, Cancer
Research, Stem Cell, Diagnostics), End User (Pharmaceutical & Biotechnology
Companies, Academic & Research Institutes) – Global Forecast to 2029.”
The report forecasts significant growth in the cell culture market, projecting
a robust compound annual growth rate (CAGR) of 11.7% from 2022 to 2029, with
the market expected to reach $48.63 billion by the end of the forecast period.
Download Free Sample PDF Copy
Here: https://www.meticulousresearch.com/download-sample-report/cp_id=4788?utm_source=article&utm_medium=social&utm_campaign=product&utm_content=06-12-2024
The anticipated growth in the cell culture market is driven
by several key factors, including the expansion of the biopharmaceutical
sector, the increasing prevalence of chronic diseases, and the growing demand
for monoclonal antibodies. Furthermore, rising investments in research and
development and the widespread adoption of single-use technologies are expected
to fuel market growth.
Market Dynamics and Opportunities
The report highlights the rapid adoption of 3D cell culture
technologies and personalized medicine as emerging trends that present
significant opportunities for market players. These advancements are poised to
revolutionize research methodologies and therapeutic approaches, further
bolstering the demand for cell culture products.
Impact of the COVID-19 Pandemic on Cell Culture Research
The COVID-19 pandemic underscored the critical role of cell
culture models in global research efforts. Understanding the transmission
dynamics and biology of the virus variants was paramount in developing
effective treatments, vaccines, and diagnostic tools. In February 2020, the
Centers for Disease Control and Prevention (CDC) played a pivotal role by
distributing the SARS-CoV-2 virus strain to research facilities worldwide,
facilitating groundbreaking studies in antiviral research, vaccine development,
and virus pathogenesis. As a result, the pandemic has had a positive impact on
the demand for cell culture products.
Market Segmentation
The cell culture market is segmented by product,
application, and end user:
- Product
Segmentation: The market is divided into consumables and equipment. In
2022, consumables are expected to account for the largest market share,
driven by the frequent and essential use of media, reagents, sera, and
cell lines in various cell culture applications.
- Application
Segmentation: The bioproduction segment is projected to lead the
market in 2022, owing to the surging demand for biopharmaceutical
products, including monoclonal antibodies, vaccines, therapeutic proteins,
and gene therapies.
- End
User Segmentation: Pharmaceutical and biotechnology companies are
anticipated to dominate the market in 2022, supported by the increasing
number of start-ups, the expansion of production and cell culture
facilities, and a heightened focus on research and development activities.
Geographic Insights
Regionally, North America is expected to lead the cell
culture market in 2022, followed by Europe and Asia-Pacific. The dominance of
North America can be attributed to its well-established healthcare
infrastructure, rapid adoption of advanced technologies, a high prevalence of
non-communicable diseases, and ongoing expansions in biopharmaceutical
manufacturing capacities. Additionally, the presence of key market players in
the region further strengthens its leadership position.
Key Market Players
Leading companies in the cell culture market include Merck
KGaA (Germany), Thermo Fisher Scientific Inc. (U.S.), Cytiva (U.S.), Lonza
Group Ltd. (Switzerland), Corning Incorporated (U.S.), Becton, Dickinson and
Company (U.S.), Avantor, Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.),
HiMedia Laboratories (India), Sartorius AG (Germany), Eppendorf SE (Germany),
FUJIFILM Holdings Corporation (Japan), Agilent Technologies, Inc. (U.S.),
Getinge AB (Sweden), Greiner Bio-One GmbH (Austria), and Miltenyi Biotec B.V.
& Co. KG (Germany).
About
Meticulous Research®
Meticulous Research® was founded in 2010 and incorporated as
Meticulous Market Research Pvt. Ltd. in 2013 as a private limited company under
the Companies Act, 1956. Since its incorporation, the company has become the
leading provider of premium market intelligence in North America, Europe,
Asia-Pacific, Latin America, and the Middle East & Africa.
The name of our company defines our services, strengths, and
values. Since the inception, we have only thrived to research, analyze, and
present the critical market data with great attention to details. With the
meticulous primary and secondary research techniques, we have built strong
capabilities in data collection, interpretation, and analysis of data including
qualitative and quantitative research with the finest team of analysts. We
design our meticulously analyzed intelligent and value-driven syndicate market
research reports, custom studies, quick turnaround research, and consulting
solutions to address business challenges of sustainable growth.
Contact
Us:
Meticulous Research®
Email- sales@meticulousresearch.com
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research
Comments
Post a Comment